ATAI
Price
$1.21
Change
+$0.02 (+1.68%)
Updated
Dec 20, 04:59 PM (EDT)
95 days until earnings call
VNDA
Price
$4.76
Change
+$0.13 (+2.81%)
Updated
Dec 20, 04:59 PM (EDT)
45 days until earnings call
Ad is loading...

ATAI vs VNDA

Header iconATAI vs VNDA Comparison
Open Charts ATAI vs VNDABanner chart's image
ATAI Life Sciences
Price$1.21
Change+$0.02 (+1.68%)
Volume$42.26K
CapitalizationN/A
Vanda Pharmaceuticals
Price$4.76
Change+$0.13 (+2.81%)
Volume$33.34K
CapitalizationN/A
ATAI vs VNDA Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. VNDA commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and VNDA is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ATAI: $1.19 vs. VNDA: $4.78)
Brand notoriety: ATAI and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 151% vs. VNDA: 146%
Market capitalization -- ATAI: $199.68M vs. VNDA: $278.42M
ATAI [@Biotechnology] is valued at $199.68M. VNDA’s [@Biotechnology] market capitalization is $278.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 6 bearish.
  • VNDA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than VNDA.

Price Growth

ATAI (@Biotechnology) experienced а -12.50% price change this week, while VNDA (@Biotechnology) price change was +3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ATAI is expected to report earnings on Mar 27, 2025.

VNDA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($278M) has a higher market cap than ATAI($200M). VNDA YTD gains are higher at: 13.270 vs. ATAI (-15.603). VNDA has higher annual earnings (EBITDA): -30.16M vs. ATAI (-124.33M). VNDA has more cash in the bank: 376M vs. ATAI (85.9M). VNDA has less debt than ATAI: VNDA (7.94M) vs ATAI (23.8M). VNDA has higher revenues than ATAI: VNDA (191M) vs ATAI (331K).
ATAIVNDAATAI / VNDA
Capitalization200M278M72%
EBITDA-124.33M-30.16M412%
Gain YTD-15.60313.270-118%
P/E RatioN/A126.00-
Revenue331K191M0%
Total Cash85.9M376M23%
Total Debt23.8M7.94M300%
FUNDAMENTALS RATINGS
ATAI vs VNDA: Fundamental Ratings
ATAI
VNDA
OUTLOOK RATING
1..100
6170
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9889
PRICE GROWTH RATING
1..100
8156
P/E GROWTH RATING
1..100
152
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (78) in the Miscellaneous Commercial Services industry is in the same range as VNDA (84) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

ATAI's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VNDA (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (89) in the Biotechnology industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

VNDA's Price Growth Rating (56) in the Biotechnology industry is in the same range as ATAI (81) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is in the same range as ATAI (15) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIVNDA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 10 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WIREX19.310.25
+1.31%
Wireless
VGINX83.691.01
+1.22%
JPMorgan US Value R6
FSIRX8.340.04
+0.48%
Fidelity Advisor Strategic Real Ret I
JEMNX9.610.01
+0.14%
JHancock Emerging Markets Equity R4
LZFIX8.32-0.98
-10.51%
Lazard Equity Franchise Inst Shr

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
N/A
FATE - ATAI
48%
Loosely correlated
+1.20%
COUR - ATAI
45%
Loosely correlated
-1.07%
VCYT - ATAI
45%
Loosely correlated
+4.66%
ALLO - ATAI
45%
Loosely correlated
+1.63%
NTLA - ATAI
45%
Loosely correlated
+0.83%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+3.24%
AMLX - VNDA
42%
Loosely correlated
+2.27%
GOSS - VNDA
37%
Loosely correlated
-0.11%
IKNA - VNDA
37%
Loosely correlated
-3.73%
VCYT - VNDA
36%
Loosely correlated
+4.66%
ATAI - VNDA
34%
Loosely correlated
N/A
More